Cancer News
Newest HER2-Targeted Therapy No Better Than Original Agent

EU Thumbs Up for Bortezomib for Mantle Cell Lymphoma

FDA Approves Olaparib (Lynparza) for BRCA Ovarian Cancer

First-ever ASCO Partnership With Pathologists

The Year in Gynecologic Cancer: Bevacizumab and Beyond
When RNA-binding proteins are turned on, cancer cells get locked in a proliferative state

Ways to prevent and manage jaw bone disease highlighted

Signaling mechanism could be target for survival, growth of tumor cells in brain cancer

Cancer genes contribute to congenital disorders

Researchers shed light on how diet influences cancer development
FDA Approves First in New Class of Drugs for Advanced Ovarian Cancer

Crohn's, Colitis May Have Genetic Underpinnings, Study Finds

Cancer Treatment Costs Weigh Heavily on Patients, Study Finds

E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds

Global Life Expectancy Continues to Climb
UCLA Cancer Researcher Named Fellow of the National Academy of Inventors

New Study Finds Promising Drug Doubled Positive Effect in Hormone-Receptor Positive Breast Cancer

FDA Approves Drug that Extends Survival in the Most Common Type of Lung Cancer

UCLA Researcher Advances Robotic Surgery Technique to Treat Previously Inoperable Head and Neck Cancer Tumors

JCCC Scientist Honored with Prestigious Biomedical Research Award
Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial

Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer

Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: A systematic review and meta-analysis

Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: A systematic review with meta-analysis

A meta-analysis of serum cancer antigen 125 array for diagnosis of ovarian cancer in Chinese